Tolerability, safety and efficacy in patients with Alzheimer's disease who are switched from donepezil to galantamine

被引：1
|
作者：
Kurz, AF
Gold, M
机构：
[1] Tech Univ Munich, D-8000 Munich, Germany
[2] Johnson & Johnson Pharmaceut Res & Dev, Titusville, NJ USA
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
10.1016/S0197-4580(04)80679-1
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S202 / S203
页数：2
相关论文
共 50 条
  • [1] A clinical perspective of the safety, tolerability, and efficacy of galantamine in patients switched from donepezil or rivastigmine.
    Edwards, K
    Therriault-O'Connor, J
    Gorman, C
    Dreyer, M
    Sethi, P
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (04) : S126 - S126
  • [2] The safety and tolerability of donepezil in patients with Alzheimer's disease
    Jackson, S
    Ham, RJ
    Wilkinson, D
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 : 1 - 8
  • [3] Donepezil: Tolerability and safety in Alzheimer's disease
    Pratt, RD
    Perdomo, CA
    Surick, IW
    Ieni, JR
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (09) : 710 - 717
  • [4] Safety and Tolerability of Donepezil, Rivastigmine and Galantamine for Patients with Alzheimer's Disease: Systematic Review of the 'Real-World' Evidence
    Lockhart, I. A.
    Mitchell, S. A.
    Kelly, S.
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 28 (05) : 389 - 403
  • [5] Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil
    Auriacombe, S
    Pere, JJ
    Loria-Kanza, Y
    Vellas, B
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (03) : 129 - 138
  • [6] First head to head study comparing the tolerability, ease of use, and efficacy of donepezil and galantamine in Alzheimer's disease
    Passmore, P
    Wetterberg, P
    Adler, G
    Bullock, R
    Soininen, H
    Aarsland, D
    Murthy, A
    Zhang, R
    Bahra, R
    [J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S97 - S97
  • [7] Comments on efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil
    McRae, TD
    Schwam, EM
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (06) : I - III
  • [8] Long-Term Safety, Tolerability, and Efficacy of a Transdermal Donepezil Patch in Patients with Severe Alzheimer's Disease
    Nakamura, Yu
    Narita, Kohei
    Kim, Rei
    Nishiyama, Kenichi
    Kikuchi, Takashi
    Ishikawa, Ichiro
    Aoki, Hiroshi
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2023, 95 (04) : 1535 - 1543
  • [9] Metaanalysis of randomized trials of the efficacy and safety of Donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease
    Ritchie, CW
    Ames, D
    Clayton, T
    Lai, R
    [J]. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 12 (04): : 358 - 369
  • [10] Response to comments on Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil
    Auriacombe, S
    Pere, JJ
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (06) : IV - VI
12345